Our first half of 2024 report on longevity inves
Browsing: All news
Category Added in a WPeMatico Campaign
Combination with NLRP3 inhibitor achieves 50% gr
As Longevity Investors Conference gets underway,
Startup pet longevity company focused on cats cl
After scrapping initial SPAC deal, Longevity Bio
GC Therapeutics’ plug-and-play stem cell progr
Global industry leaders converge in Singapore to
As the International Longevity Summit approaches
Phase 2 study data indicates ‘dose-dependent i
Company aims to inhibit SARM1 enzyme to prevent